{
    "clinical_study": {
        "@rank": "14785", 
        "acronym": "ESECC", 
        "arm_group": [
            {
                "arm_group_label": "Control Arm", 
                "arm_group_type": "No Intervention", 
                "description": "Participants in this arm will not accept the endoscopy screening. And only baseline and follow-up interview and an alternative abdominal ultrasound scan will be conducted in this arm."
            }, 
            {
                "arm_group_label": "Screening Arm", 
                "arm_group_type": "Experimental", 
                "description": "Participants in this arm will accept a baseline endoscopy screening and questionnaire investigation and follow-up interview. If applicable, all participants in this arm will accept a second endoscopy screening in the 5th year of the study."
            }
        ], 
        "brief_summary": {
            "textblock": "The purposes of this study are as follows:\n\n        1. Establish clinical criteria of endoscopy screening on esophageal cancer in high risk\n           region of China;\n\n        2. Evaluate the efficacy of endoscopy screening on esophageal cancer;\n\n        3. Determine the most cost-effective strategy of endoscopy  screening in high risk\n           population of China."
        }, 
        "brief_title": "Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)", 
        "completion_date": {
            "#text": "December 2022", 
            "@type": "Anticipated"
        }, 
        "condition": "Esophageal Squamous Cell Carcinomas", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Esophageal Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. permanent residency in one of the 334 target villages which were randomly selected\n             from all the 968 villages of Hua County of Anyang, China;\n\n          2. age between 40 and 69 years;\n\n          3. willingness to participate in this study and complete all parts of the examination.\n\n        Exclusion Criteria:\n\n          1. self-reported history of cancer, cardiovascular disease, mental disorder, or other\n             contraindications for endoscopy;\n\n          2. self-reported history of infection with hepatitis B virus (HBV), hepatitis C virus\n             (HCV), or human immunodeficiency virus (HIV), and any evidence of these infections\n             based on serum screening;\n\n          3. history of endoscopy examination within 5 years prior to the interview."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "69 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "32000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688908", 
            "org_study_id": "201202014"
        }, 
        "intervention": {
            "arm_group_label": "Screening Arm", 
            "description": "Upper G.I. endoscopy examination with Lugols Iodine in esophagus\nBiopsy at the visually abnormal sites\nPathologic examination of all biopsy tissue specimens\nAdvise of regular re-examination will be given to participants who are diagnosed of moderate and severe dysplasia.\nAdvises of endoscopic or surgical treatment will be given to participants who are diagnosed of early upper G.I. carcinomas.", 
            "intervention_name": "Endoscopy Screening", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Esophageal Squamous Cell carcinomas", 
            "Endoscopy Screening", 
            "High risk region", 
            "China"
        ], 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "contact": {
                "email": "drhcai@gmail.com", 
                "last_name": "Hong Cai, M.D.", 
                "phone": "8610-88196762"
            }, 
            "contact_backup": {
                "email": "zhonghuhe@gmail.com", 
                "last_name": "Zhonghu He, Ph.D.", 
                "phone": "8610-88196762"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Bejing", 
                    "zip": "100142"
                }, 
                "name": "Laboratory of Genetics, Beijing Cancer Hospital and Institute, Peking University"
            }, 
            "investigator": {
                "last_name": "Hong Cai, M.D.", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Endoscopy Screening on Esophageal Cancer in a High Risk Region of Rural China: a Randomized Controlled Trial", 
        "other_outcome": {
            "measure": "Cost of saving 1 person-year of life", 
            "safety_issue": "No", 
            "time_frame": "5-10 years"
        }, 
        "overall_contact": {
            "email": "drhcai@gmail.com", 
            "last_name": "Hong Cai, M.D.", 
            "phone": "8610-88196762"
        }, 
        "overall_contact_backup": {
            "email": "zhonghuhe@gmail.com", 
            "last_name": "Zhonghu He, Ph.D.", 
            "phone": "8610-88196762"
        }, 
        "overall_official": {
            "affiliation": "Peking University", 
            "last_name": "Yang Ke, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Esophageal cancer specific mortality", 
            "safety_issue": "No", 
            "time_frame": "5-10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688908"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University", 
            "investigator_full_name": "Yang Ke", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Cumulative incidence of advanced esophageal cancer", 
            "safety_issue": "No", 
            "time_frame": "5-10 years"
        }, 
        "source": "Peking University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}